Mutation Analysis and Embryonic Expression of the HLXB9 Currarino Syndrome Gene  by Hagan, D.M. et al.
Am. J. Hum. Genet. 66:1504–1515, 2000
1504
Mutation Analysis and Embryonic Expression of the HLXB9 Currarino
Syndrome Gene
D. M. Hagan,1,* A. J. Ross,1,* T. Strachan,1 S. A. Lynch,1 V. Ruiz-Perez,1 Y. M. Wang,1
P. Scambler,2 E. Custard,2 W. Reardon,3 S. Hassan,2 M. Muenke,8 P. Nixon,2 C. Papapetrou,2
R. M. Winter,3 Y. Edwards,4 K. Morrison,4 M. Barrow,9 M. P. Cordier-Alex,10 P. Correia,11
P. A. Galvin-Parton,12 S. Gaskill,13 K. J. Gaskin,14 S. Garcia-Minaur,15 R. Gereige,16
R. Hayward,5 T. Homfray,7 C. McKeown,17 V. Murday,7 H. Plauchu,10 N. Shannon,18 L. Spitz,6
and S. Lindsay1
1Human Genetics Unit, School of Biochemistry and Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne; 2Molecular
Medicine Unit and 3Department of Clinical Genetics and Fetal Medicine, Institute of Child Health, 4MRC Human Biochemical Genetics Unit,
University College, 5Department of Neurosurgery and 6Nuffield Department of Surgery, Great Ormond Street Hospital for Children, and
7Department of Medical Genetics, St. Georges Hospital Medical School, London; 8Medical Genetics Branch, National Human Genome
Research Institute, Bethesda; 9Department of Clinical Genetics, Leicester Royal Infirmary, Leicester; 10Hopital Hotel Dieu, Lyon; 11IFF-Fiocruz,
Rio de Janeiro; 12Department of Pediatrics, State University of New York at Stony Brook, Stony Brook; 13Medical Drive, San Antonio; 14Royal
Alexandra Hospital for Sick Children, Camperdown, New South Wales, Australia; 15Clinica Materno-Infantil, Hospital de Cruces, Barakaldo,
Spain; 16All Children’s Hospital, St. Petersburg, FL; 17Clinical Genetics Unit, Birmingham Women’s Hospital, Birmingham, United Kingdom;
and 18Centre for Human Genetics, Sheffield
The HLXB9 homeobox gene was recently identified as a locus for autosomal dominant Currarino syndrome, also
known as hereditary sacral agenesis (HSA). This gene specifies a 403–amino acid protein containing a homeodomain
preceded by a very highly conserved 82–amino acid domain of unknown function; the remainder of the protein is
not well conserved. Here we report an extensive mutation survey that has identified mutations in the HLXB9 gene
in 20 of 21 patients tested with familial Currarino syndrome. Mutations were also detected in two of seven sporadic
Currarino syndrome patients; the remainder could be explained by undetected mosaicism for an HLXB9 mutation
or by genetic heterogeneity in the sporadic patients. Of the mutations identified in the 22 index patients, 19 were
intragenic and included 11 mutations that could lead to the introduction of a premature termination codon. The
other eight mutations were missense mutations that were significantly clustered in the homeodomain, resulting, in
each patient, in nonconservative substitution of a highly conserved amino acid. All of the intragenic mutations
were associated with comparable phenotypes. The only genotype-phenotype correlation appeared to be the oc-
currence of developmental delay in the case of three patients with microdeletions. HLXB9 expression was analyzed
during early human development in a period spanning Carnegie stages 12–21. Signal was detected in the basal
plate of the spinal cord and hindbrain and in the pharynx, esophagus, stomach, and pancreas. Significant spatial
and temporal expression differences were evident when compared with expression of the mouse Hlxb9 gene, which
may partly explain the significant human-mouse differences in mutant phenotype.
Introduction
The combination of partial absence of the sacrum, an-
orectal anomalies, and a presacral mass (anterior men-
ingocoele or teratoma) constitutes Currarino syndrome,
also known as “Currarino triad” (MIM 176450) (Cur-
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rarino et al. 1981). Radiography of patients reveals pres-
ervation of the first sacral vertebra with a hemisacrum
(sickle-shaped) remnant of sacral vertebrae 2–5 (S2–S5),
either to the right or left. The anorectal abnormalities
include imperforate anus, ectopic anal position, and a
variety of inappropriate connections, either to the spinal
cord or to the urogenital system. Considerable intrafam-
ilial variation in expressivity is seen, including presen-
tation in the neonate with acute bowel obstruction sec-
ondary to an imperforate anus, a history of chronic
constipation from early childhood, and, at the mild end,
asymptomatic individuals with sacral abnormalities.
The malformations seen in Currarino syndrome are
in tissues that have their embryological origin in the tail
bud and may reflect disturbances of secondary neuru-
lation, a process that occurs during early development
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Figure 1 Location of intragenic HLXB9 mutations. A, Spectrum
of missense and chain-terminating mutations. The three exons of
HLXB9 gene are denoted by rectangular boxes with the coding se-
quences emphasized by wider boxing than that used for the flanking
5′ and 3′ UTR sequences. Missense mutations are denoted by asterisks
(*) above the exons. The locations of different classes of chain-ter-
minating mutations are indicated by lettering below the gene, as fol-
lows: I = frameshifting insertions; D = frameshifting deletions; X =
nonsense mutations; Sp = splice-site mutation. B, Amino acid substi-
tutions resulting from missense mutations. Substituted amino acids are
indicated by bold, underlined letters, and the derived mutant residues
are shown in bold above the arrowheads. The W290G mutation was
found in two unrelated patients (35 and 37; see table 1). Reference
sequences were derived as follows: HLXB9: Harrison et al. (1994),
corrected for codon 264 from our unpublished data; mouse Hlxb9
(formerly Hb9): Arber et al. (1999) and Thaler et al. (1999); chick
(Gallus Gallus) HB9: Pfaff et al. (1996); Xenopus (xHB9): Saha et al.
(1997); sea urchin (PIHbox9): Bellomonte et al. (1998); chick Mnr2:
Tanabe et al. (1998). Dashes denote identity. As can be seen from the
figure, the homeodomain of Mnr2 is highly homologous to that of
HLXB9, but, outside the homeodomain, the proteins are not related.
Mnr2 is expressed in dividing neuroblasts and plays a major role in
motor neuron specification in the chick (Tanabe et al. 1998).
(Pang 1993; Lynch et al. 1995). In the human tail bud,
the neural tube, notochord, somites, and hindgut all
arise from a mass of pluripotential cells in the period
commencing at Carnegie stage 12 (CS12 = 26 posto-
vulatory d [POD]) (O’Rahilly and Muller 1987). A pri-
mary notochordal defect in the tail bud leading to its
nonformation or mispositioning has been proposed as
an explanation for the pathogenesis in Currarino syn-
drome (Currarino et al. 1981; Lynch et al. 1995).
We have mapped the locus for autosomal dominant
Currarino syndrome, also called “hereditary sacral
agenesis” (HSA), to chromosome 7q36 (Lynch et al.
1995). We recently reported elsewhere that patients
with HSA have mutations in the HLXB9 gene (Ross et
al. 1998), a homeobox gene (formerly called HB9),
which was first identified because of its expression in
pancreatic and lymphoid tissues (Harrison et al. 1994).
HLXB9 has three exons and encodes a protein of 403
amino acids with three significant features (fig. 1A): a
polyalanine repeat region which shows length poly-
morphism; a homeodomain encoded by exons 2 and 3
(see Harrison et al. 1994) and conserved among HLXB9
homologues but not among other homeobox genes
(with the exception of Mnr2—see fig. 1B); and a highly
conserved region of 82 amino acids upstream of the
homeodomain (Harrison et al. 1994; Saha et al. 1997;
A. J. Ross, T. Strachan, and S. Lindsay, unpublished
data).
Two Hlxb92/2 strains of knockout mice have been
described, but both of their phenotypes are rather dif-
ferent from that shown by human patients. Heterozy-
gotes have no discernible phenotype, but the two ho-
mozygous knockouts show similar abnormalities of
pancreatic (Harrison et al. 1999; Li et al. 1999) and
motor-neuron development (Arber et al. 1999; Thaler
et al. 1999), neither of which is evident in patients with
HLXB9 mutations. In addition, neither of the mouse
mutants had any detectable disruption of sacral or hind-
gut development.
In the present study, we report HLXB9 mutation
analyses in 28 patients with familial or sporadic Cur-
rarino syndrome. Mutations were detected in 20 of 21
patients with familial Currarino syndrome and in 2 of
7 patients with sporadic Currarino syndrome. Similar
phenotypes were attributable to a variety of different
classes of intragenic mutation, consistent with patho-
genesis caused by loss of function. Missense mutations
were identified in a total of eight unrelated index pa-
tients with Currarino syndrome. All of the missense mu-
tations mapped to the homeobox, and none mapped to
the highly conserved domain preceding it. Screening of
a group of mainly sporadic patients with related or par-
tial phenotypes or additional atypical features failed to
detect HLXB9 mutations. We also report an extended
study of HLXB9 embryonic expression, which has re-
vealed significant human-mouse differences in both spa-
tial and temporal expression patterns. We discuss these
findings in the light of the highly significant human-
mouse differences in the associated phenotypes.
Patients and Methods
Patients
Ethical permission for the study was given by the Joint
Ethics Committee of the Newcastle Health Authority.
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Table 1
HLXB9 Mutations Identified in the Study and Associated Phenotypesa





Missense Homeobox CrG, nt 4171 R247G Hemisacrum, ARM, presacral mass, perianal abcess 3
GrA, nt 4172 R247H Hemisacrum, ARM, presacral mass 13
TrG, nt 4900 W290G Hemisacrum, ARM, presacral mass, rectovaginal
fistula, neurogenic bladder
35c
TrG, nt 4900 W290G Hemisacrum, ARM, presacral mass, tethered cord 37c
GrT, nt 4901 W290L Hemisacrum, ARM, presacral mass 30
ArC, nt 4907 Q292P Hemisacrum, ARM, presacral mass, 5
CrT, nt 4912 R294W Hemisacrum, ARM, presacral mass, vesico-ureteric
reflux
38
GrA, nt 4916 R295Q Hemisacrum, ARM presacral mass, renal
malformation
14
Splice Site Homeobox ArG, nt 4889 NA Hemisacrum, ARM, presacral mass,
nonpenetranced
16
Frameshift Exon 1 Ins C, nt 125-30 NA Hemisacrum, ARM, presacral mass, neurogenic
bladder, nonpenetrance
20
Ins C, nt 125-30 NA Hemisacrum, ARM, presacral mass (detected
antenatally)
23
Del G, nt 408-13 NA Hemisacrum, ARM, presacral mass 26
Del C, nt 414-17 NA Hemisacrum, ARM, presacral mass 19
Del 14nt, nt 483-96 NA Hemisacrum, ARM, presacral mass 27
Del G, nt 486-90 NA Hemisacrum, ARM, presacral mass, tethered cord 36
Del A, nt 652-53 NA Hemisacrum, ARM 2
Del A, nt 652-53 NA Hemisacrum, ARM, presacral mass 33
Nonsense Exon 1 CrA, nt 575 Y166X Sporadic, hemisacrum, ARM, presacral mass, teth-
ered cord
29





NA NA Hemisacrum, ARM, developmental delay 6
NA NA Absent sacrum/short stature/single central incisor,
developmental delay
32
NA NA Sporadic, hemisacrum, ARM, presacral mass, teth-
ered cord, developmental delay
34
a In addition to patient-specific mutations, polymorphisms were also detected: del C in a run of 4Cs at positions 2519 to 2522 (frequency
of del C allele = .1); C/G at –293 bp upstream of ATG (frequency of G allele = .175); A/G 92 bp into intron 2 from the 5′ end (frequency of
G allele = .09); T/C 131 bp upstream of exon 3 (frequency of C allele = .44).
b All patients are familial except, as indicated, sporadic patients 29 and 34. The clinical features documented in the familial patients are
descriptive of the range of features seen collectively (i.e., not all features were present in all individuals.) ARM = anorectal malformation.
c Although these two families have the same mutation, haplotype analysis using very closely linked proximal and distal markers strongly
suggests that they arose independently (see Results).
d Nonpenetrance in at least one family member.
e One death in affected from brain tumor; possible malignant change in known teratoma.
Patients showing Currarino syndrome (including three
with developmental delay) were investigated. The clin-
ical details of families 1, 2, 14, 16, 19, 20, 23, 27, and
29 have been reported elsewhere (Cavero Vargas et al.
1992, Hardwick et al. 1992; Gaskill and Marlin 1996;
Ross et al. 1998 and references therein). DNA samples
from 28 index patients and their families were prepared
and analyzed. The phenotypes of the patients in whom
we found a mutation are given in table 1. The family in
which we did not identify an HLXB9 mutation (family
24) initially presented following the birth of a child with
Currarino syndrome. Features noted included anal atre-
sia, a partial sacral agenesis, and a presacral mass. As
children, the child’s father and paternal uncle had sur-
gery to remove teratomas from the intestine and med-
istinum, respectively. Sacral X-rays were not available
from either.
DNA samples from a further 32 patients with partial,
atypical, or related phenotypes were also investigated.
They comprised patients with anorectal malformations
( ), with sacral agenesis ( —these patients didn = 9 n = 12
not have hemisacrum, and some had additional malfor-
mations), with sacroccocygeal teratomas ( ), andn = 2
with spina bifida occulta ( ).n = 9
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Mutation Analysis
Nine overlapping oligonucleotide primer pairs were
designed to amplify the HLXB9 coding region by PCR
(fig. 1A). They were four primer pairs in exon 1
(1A–1D), one in exon 2, and four in exon 3 (3A–3D).
The precise positions of the primer pairs are shown in
the study by Ross et al. (1998). Their sequences are given
in the 5′r3′ direction in the accompanying table (Elec-
tronic-Database Information Section). Primers were also
designed to amplify two segments of intron 2 (intron 2
5′ and intron 2 3′) and to span a putative promoter region
of the gene. Features within the putative promoter re-
gion, which extends ∼750 bp upstream of the presumed
ATG start codon, include a potential CAAT box
(121–125 bp upstream of the ATG) as well as 12 GC
boxes (SP1 binding sites). As with other CpG island
genes, there is no TATA box. The putative promoter was
amplified using three primer pairs—PRA, PRB, and
PRC. The sequences of these primers and the intronic
primers are also given in the accompanying table (Elec-
tronic-Database Information).
PCR reactions and SSCP gel analysis were carried out
as described elsewhere (Ross et al. 1998). All of the PCR
mixes were supplemented with 2 M Betaine, with the
exception of that for primer pair 1D, which was sup-
plemented with 7.5% dimethyl sulfoxide. When a re-
producible alteration was identified by SSCP gel analysis,
the corresponding PCR fragment was cloned and se-
quenced as described elsewhere (Ross et al. 1998), to
define the nature of the sequence change.
Microsatellite Analyses
Microsatellite analyses were carried out as described
by Ross et al. (1998). The HLXB9 gene was related to
marker order by the following sequence: centromere-
D7S637-EN2-D7S550-CGR13-D7S559-HLXB9-
CGR16-D7S2423-D7S594-telomere (Ross et al. 1998;
Heus et al. 1999).
In Situ Hybridization on Human Embryo Sections
Collection and use of human embryos was carried out
with ethical permission from the Joint Ethics Committee
of the Newcastle Health Authority and with the appro-
priate signed consents. Embryos were collected, follow-
ing either surgically or medically induced termination of
pregnancy (Bullen et al. 1998) and were staged by mi-
croscopic examination. Their fixation and processing for
in situ hybridization are as described by Ross et al.
(1998), as are the HLXB9 sense and antisense probes
and the in situ hybridization procedures. At all stages,
adjacent sections were hybridized with antisense
HLXB9 or sense HLXB9 probes. No signal was detected
with the control sense probes (data not shown).
Results
Mutation Analyses
Patients were considered to have Currarino syndrome
if they showed all three major features of the disor-
der—partial sacral agenesis (hemisacrum and not in-
volving the first sacral vertebra [S1]), constipation or
anorectal malformation, and presacral mass. In all cases
(except family 2), at least one family member showed
all three major features. Family 2 refused further clinical
investigations, so the presence of a presacral mass could
not be confirmed. In another family (33), however, the
same mutation caused Currarino syndrome. The phe-
notypes found in the 22 families and sporadic patients
in whom we detected a mutation are given in table 1.
The intragenic mutations were not found in a panel of
258 control chromosomes. In three of the patients (6,
32, and 34) pathogenesis was due to a microdeletion
that encompassed the HLXB9 gene, as revealed by mi-
crosatellite typing using eight markers in the
D7S637–D7S594 interval (see Methods; data not
shown). Two of these patients, 6 and 34, had Currarino
syndrome and developmental delay. In addition to these
features, the third patient, 32, had a single maxillary
incisor, a feature associated with holoprosencephaly.
The remaining 19 index patients (patients from 18
families and one sporadic patient) revealed intragenic
mutations (see table 1). They consisted of eight frame-
shifting insertions/deletions, two nonsense mutations
(one in exon 1 and one leading to a premature stop
codon in the homeobox), a splice-site mutation (at the
intron 2 splice acceptor), and eight missense mutations.
Of the total of 19 intragenic mutations, there were 17
different mutations: families 2 and 33 have identical sin-
gle-base deletions, whereas families 35 and 37 exhibited
the same missense mutation. Families 2 and 33 both
come from the same city in the north of England, and,
although we have not been able to trace a link between
them, it is likely that they are related. Families 35 and
37, however, were shown by microsatellite analyses to
be carrying the mutation on chromosomes with quite
different flanking markers. The haplotypes for the se-
quence of markers (cen-EN2-D7S550 -CGR13-D7S559-
CGR16-D7S2423-D7S594-tel) were unambiguously de-
rived as follows: 3-4-5-8-4-4-3 in family 35 and
3-2-1-5-3-2-2 in family 37 (data not shown). Because
the marker D7S559 is 180 kb proximal to HLXB9 and
CGR16 is only 110 kb distal to HLXB9 (Heus et al.
1999), these data support the view that the same mis-
sense mutation has occurred independently in families
35 and 37.
The position of the intragenic mutations is summa-
rized in figure 1A. It is remarkable that all eight missense
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mutations cluster in the homeobox even though the up-
stream sequence specifies a very highly conserved do-
main of 82 amino acids of unknown function. Each of
the missense mutations result in nonconservative amino
acid substitution in the homeodomain, involving amino
acids in the third helix in five patients and two different
substitutions of an arginine residue at the fifth amino
acid position of the N-terminal arm (fig. 1A, B). In each
patient, the substituted amino acid is one that has been
highly conserved in evolution, being present in HLXB9
orthologues in mouse, chick, Xenopus, and sea urchin
and also in the homeodomain of the related chick Mnr2
gene (fig. 1B).
In addition to patients with Currarino syndrome, we
also screened a further 32 patients with overlapping,
atypical, or related phenotypes. They consisted of pa-
tients with anorectal malformations ( ), sacral agen-n = 9
esis ( ; these patients did not have hemisacrum andn = 12
some had additional malformations), sacroccocygeal ter-
atomas ( ), and spina bifida occulta ( ); how-n = 2 n = 9
ever, no HLXB9 mutations were detected.
Embryonic Expression of HLXB9
As detailed in the Introduction, there are substantial
human-mouse differences in mutant phenotypes asso-
ciated with loss-of-function HLXB9/Hlxb9 mutations.
Although patients with Currarino syndrome are heter-
ozygotes and the mutant-mouse phenotype is observed
only in homozygotes, parallel examples are known with
comparable phenotypes in human heterozygotes and
mouse homozygotes (e.g., mutant sonic hedgehog phe-
notypes [reviewed in Ming and Muenke 1998]). This
may suggest that there are other differences in the ex-
pression or function of HLXB9/Hlxb9 that are signifi-
cant for understanding the human disease. Although de-
tailed embryonic-expression studies have only recently
been initiated to study human genes, human-mouse dif-
ferences have already been identified in embryonic ex-
pression for a variety of human disease genes and de-
velopmental control genes (see Fougerousse et al. 2000
and references therein).
We elsewhere reported a study of HLXB9 expression
in embryonic sacral development (Ross et al. 1998). In
the current study, we carried out detailed, embryowide
analyses of HLXB9 expression. The malformations seen
in Currarino syndrome are in tissues that have their em-
bryological origin in the tail bud. The formation in the
human tail bud of the definitive notochord, the hindgut,
and caudal skeletal elements and the process of second-
ary neurulation occur in the period commencing at CS12
(O’Rahilly and Muller 1987). We have therefore carried
out expression analyses to cover the period from CS12
to CS21, corresponding to 26–52 POD.
HLXB9 expression was detected in the neural tube at
CS12 (26 POD), and by CS14 (31 POD) it was evident
in the anterior horns (where motor neurons develop) and
in the adjacent subventricular region. The population of
cells in the anterior horns was detectable along the length
of the neural tube (fig. 2b) and throughout the devel-
opmental period studied. The signal in the subventri-
cular zone, however, gradually disappeared in a rostral
to caudal direction: at CS19 it was not detectable at the
level of the esophagus but was still present in the sacral
region, where, in turn, the signal was not detectable by
CS21 (fig. 2d–f and data not shown). Expression also
extended rostrally into the hindbrain (the pyramidal
tract region of the future medulla oblongata [fig. 2b]).
By CS15 (33 POD) clear expression of HLXB9 was
detected in the pharynx (data not shown) and the esoph-
agus (fig. 3b), which persisted through all the develop-
mental stages examined (see, e.g., fig. 2b). Foregut ex-
pression extended caudally as far as the developing
stomach (fig. 3d) until CS17, after which time it was no
longer detectable. In addition, at CS15, HLXB9 was
clearly detected in the dorsal pancreatic bud (data not
shown), which arises from the most caudal region of the
foregut. From CS17 (41 POD) onward, pancreatic ex-
pression of HLXB9 was seen in both the dorsal bud and
the now discernible ventral bud of the developing pan-
creas (fig. 3f). Expression appeared to be of similar in-
tensity in both dorsal and ventral pancreatic buds, and
HLXB9 remained strongly expressed at CS19 and CS21
(fig. 3h and data not shown). No expression was seen
in the midgut (fig. 2b) or hindgut throughout the em-
bryonic period studied (data not shown). We did not
detect expression in the notochord (in the sacral region
or any other region; data not shown), and in the period
studied the only sacral region where signal could be de-
tected was in the spinal cord (see above and fig. 3h).
Discussion
HLXB9 Mutations Account for the Pathogenesis of the
Vast Majority of Patients with Familial Currarino
Syndrome But Are Evident Only in a Proportion of
Sporadic Patients
We identified HLXB9 mutations in 20 of 21 families
and two of seven sporadic patients with Currarino syn-
drome, giving an aggregate 79% detection rate for in-
dependent mutations resulting in Currarino syndrome.
We detected three instances of new mutations: two oc-
curred in sporadic patients (29 and 34); the other one
in an individual who subsequently transmitted the dis-
ease (3). The parent of origin was maternal in one pa-
tient, paternal in the second, and we were unable to
determine it in the third patient. The HLXB9 gene cod-
ing and putative promoter regions were sequenced in
Figure 2 Basal plate expression of HLXB9. A, Bright field microscopy of a CS18 (44 POD) sagittal section stained with hematoxylin
and eosin. B, Dark field microscopy of an adjacent section following in situ hybridization of antisense HLXB9 probe. Expression can be seen
throughout the length of the spinal cord (where present in the section; indicated as NT) and into the hindbrain. Expression is also seen in the
developing esophagus but is not detectable in the midgut (arrows). C, High-power view of a transverse section of spinal cord in a CS17 (41
POD) embryo stained with hematoxylin and eosin and, D, corresponding dark-field view with expression clearly absent from the layer nearest
the neural tube lumen (ventricular layer) and strongly detected in the subventricular and outer layers. E and F, Dark field views of expression
in transverse sections of the spinal cord of a CS19 embryo at the level of the esophagus (E) or sacrum (F). At both levels, expression is clearly
seen in the anterior horns, but by this stage expression is not detectable in the subventricular layer rostrally in the spinal cord (E) but is still
detectable in more caudal regions (F). Adjacent sections in all patients were hybridized to sense HLXB9 probe as a control. No specific signals
were detected (data not shown). Bar = 500 mm. Indicated tissues are AH, anterior horn; BP, basal plate; FB, forebrain; HB, hindbrain; H, heart;
L, liver; mg, midgut; NT, neural tube; O, (o)esophagus; and SV, subventricular layer.
Figure 3 Expression of HLXB9 in CS15 (a–d), CS17 (e and f), and CS19 (g and h) human embryos. The figure shows dark field
photomicrographs of antisense HLXB9 probe following in situ hybridization to transverse sections of CS15 (b and d), CS17 (f), and CS19 (h)
embryos. Bright field microscopy of adjacent sections (a, c, e, and g, respectively) stained with hematoxylin and eosin are shown for orientation.
Adjacent sections in each patient were hybridized to sense HLXB9 probe as a control. No specific signals were detected (data not shown). At
all three stages (CS15, CS17, and CS19), signal is clearly detected in the anterior horns of the spinal cord (b, d, f, h). At CS15, expression is
detected in the developing esophagus (b) and stomach (d). At CS17, expression is detected in both the dorsal and ventral pancreas (f) and is
still detectable in the pancreas at CS19 (h). At CS19, expression is not detected in the stomach (h). Bar = 500 mm. DP = dorsal pancreas; L =
liver; O = (o)esophagus; P = pancreas; S = stomach; SC = spinal cord; VP = ventral pancreas.
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five of the index patients with Currarino syndrome (one
familial and four sporadic) in whom no mutation was
detected by SSCP, but this did not reveal any mutations
(data not shown). It remains possible that mutations
elsewhere in the HLXB9 gene may lead to the clinical
phenotype, or, in the case of the sporadic patients, per-
haps the mutation is not present in blood cells because
of somatic mosaicism. Mutations leading to differential
allele expression could be assessed using the intragenic
exon 1 polymorphism specifying the variable-length po-
lyalanine region, but, unfortunately, RNA samples were
unavailable to us. We were also unable to obtain dif-
ferent tissue samples from the sporadic patients to test
for somatic mosaicism.
The family in which we have not found a mutation
in the HLXB9 gene could indicate that there is genetic
heterogeneity in familial Currarino syndrome. Linkage
studies in this family are consistent with a locus on 7q36,
however, although, because this is a small family, the
LOD score is not significant (data not shown). The index
patient in this family has all three features typical of
Currarino syndrome, but the other two affected mem-
bers of the family (her father and paternal uncle) have
very atypical phenotypes (family 24; see Patients and
Methods). It is, therefore, not clear whether the disorder
is familial or the index patient is sporadic. Thus, al-
though we cannot completely exclude the possibility of
low-level heterogeneity, the mutation data presented
here coupled with the fact that linkage analyses in all
suitably large families are consistent with a single locus
on 7q36 (Lynch et al. 1995; Vargas et al. 1998) strongly
implicate HLXB9 as the sole cause for familial Currar-
ino syndrome.
HLXB9 mutations were detected in only a portion of
sporadic patients with Currarino syndrome. Although
mutations outside the coding and putative promoter
regions and somatic mosaicism provide possible expla-
nations, an alternative possibility is genetic heteroge-
neity. Possible candidate genes include genes known to
be involved in the same pathways as HLXB9. Isl1 and
Lim3, like Hlxb9, are involved in motor neuron devel-
opment (Pfaff et al. 1996), and, like Hlxb9, Isl1 is also
important in pancreas development (Harrison et al.
1999; Li et al. 1999). We used SSCP analyses to screen
for mutations in the coding sequence of ISL1 in the
sporadic Currarino syndrome patients who do not have
an HLXB9 mutation, but no sequence changes were
detected other than an already reported silent polymor-
phism at codon 168 (Riggs et al. 1995; A. J. Ross, T.
Strachan, and S. Lindsay, unpublished data). At the time
of this writing, the sequence of the human LIM3 gene
was unavailable; when this and the sequences of other
interacting human genes become available, they too can
be screened.
In contrast to patients with Currarino syndrome,
HLXB9 mutations were not detected in the group of 32
patients with atypical or partial or related phenotypes.
Among them were nine patients with spina bifida oc-
culta, a defect in which the vertebral arches, most com-
monly in the lumbar-sacral region, fail to fuse (Anderson
1975). This condition occurs sporadically and in families
with neural tube defects and is, like Currarino syndrome,
thought to be a defect of secondary neurulation (Pang
1993; Mclone and Dias 1994a, 1994b); however, pa-
tient-specific mutations were not evident in these pa-
tients.
Different Mutation Classes Produce Comparable
Phenotypes, Most Likely as a Result of
Haploinsufficiency, But Missense Mutations Are
Significantly Clustered in the Homeobox
Our initial report described mutations that could re-
sult in premature introduction of a stop codon in
HLXB9 (Ross et al. 1998). The current study now pro-
vides a variety of disease-associated missense mutations.
In addition, it provides further evidence that the phe-
notype is due to haploinsufficiency, because different
mutation classes (7q36 microdeletions, missense muta-
tions, nonsense mutations, frameshifting deletions, and
splice-site mutations) all produce comparable pheno-
types (table 1). The phenotypes in the patients with mi-
crodeletions not unexpectedly also showed developmen-
tal delay. In one patient , 32, there was also evidence of
holoprosencephaly. FISH analyses using SHH cosmid
probes have demonstrated that the SHH gene is also
deleted in this patient (32; data not shown). There were
no clear correlations between mutation type and severity
of disease or incidence of specific clinical feature (sacral
agenesis, anorectal malformation, constipation, anterior
meningocoele, lipoma/teratoma, malignancy, perianal
sepsis, spinal cord tethering [table 1 and data not
shown]). Individual mutations were, however, frequently
accompanied by variable expressivity in families with
multiple affected individuals. About 1/3 presented as ne-
onates or in early childhood requiring surgical interven-
tion, whereas other symptomatic individuals were able
to be managed conservatively, thus avoiding surgery (S.
A. Lynch, unpublished observations). Many affected in-
dividuals were asymptomatic but usually had evidence
of sacral abnormalities on X-ray, with the exception of
two families where nonpenetrance was a feature (fam-
ilies 16 and 20) (table 1 and Ross et al. 1998).
All of the identified missense mutations result in sub-
stitution of a very highly conserved amino acid that ap-
pears from in vitro assays to be involved in the binding
of the homeodomain to the target DNA motif TAAT
(Kissinger et al. 1990; Gehring et al. 1994). Four of the
substituted amino acids (W48, Q50, R52, and R53) are
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in helix 3, the recognition helix. The fifth (R5) is one of
the small number of residues in the N-terminal arm (oth-
erwise largely involved in protein-protein interactions
[Di Rocco et al. 1997]) that have also been shown to
be important for binding to TAAT. The importance in
vivo of these specific amino acid positions in the hom-
eodomain has been underscored by parallel findings in
other homeobox genes underlying human genetic dis-
orders (see, e.g., Dattani et al. 1998; Villa et al. 1998;
Swaroop et al. 1999).
It is striking that all missense mutations reported here
are in the homeobox. Although we identified seven dif-
ferent missense mutations (fig. 1A, B), the identification
of identical missense mutations in two unrelated families
with entirely different marker haplotypes (35 and 37;
see Results and table 1) strongly suggests eight indepen-
dent missense mutations. To our knowledge, only two
other HLXB9 missense mutations have been identified
in Currarino syndrome patients, and they too are located
in the homeobox resulting in R295W and T248S sub-
stitutions (Belloni et al. 2000). Thus, 10/10 missense
mutations map to the homeobox, although the sequence
immediately upstream encodes a highly conserved 82–
amino acid domain of unknown function. The size of
this domain varies slightly in orthologues, principally as
a result of length variation in a second polyalanine repeat
region distinct from the polymorphic polyalanine tract.
Outside this length variation, the HLXB9 sequence
shows 196%, 91%, and 80% identity to orthologues in
mouse, chick, and Xenopus, respectively. Possibly, as
with many other homeobox genes, the second highly
conserved domain encoded by HLXB9 could have a reg-
ulatory role and/or be involved in protein-protein as-
sociations. In this case, it is conceivable that amino acid
substitutions in this domain could give rise to different
clinical phenotypes.
HLXB9 Expression in Early Human Embryos Shows
Significant Differences When Compared with the
Mouse Orthologue, But Neither Expression Pattern Is
Easily Related to the Human Phenotype
A primary notochordal defect in the tail bud leading
to its nonformation or mispositioning has been proposed
as an explanation for the pathogenesis in Currarino syn-
drome (Currarino et al. 1981; Lynch et al. 1995). The
consistent inability to detect HLXB9 expression in tail
bud notochord from CS12 onward (data not shown),
or in more anterior regions of the notochord (figs. 2 and
3), could conceivably reflect very low-level HLXB9 ex-
pression that is undetectable by standard in situ hybrid-
ization techniques. It is also possible that significant ex-
pression occurs in notochordal/prenotochordal tissue at
stages prior to CS12. In the mouse, very recent reports
have described early notochordal expression for Hlxb9,
both in the tail bud and more anteriorly, and this ex-
pression pattern can no longer be detected by E10, which
corresponds approximately to CS12 (Harrison et al.
1999; Li et al. 1999). If HLXB9 is expressed in the
human notochord, therefore, it may be affecting very
early notochord formation, and it could be downstream
“effectors” that are active at the time of definitive no-
tochord and vertebral formation.
HLXB9 expression was detected in developing human
motor neurons (mostly postmitotic neurons in the an-
terior horn) throughout the length of the developing spi-
nal cord, as well as in the basal plate of the hindbrain
(fig. 2b). Although, in Xenopus and chick, Hlxb9 ex-
pression is detected only in postmitotic motor neurons
(Saha et al. 1997; Tanabe et al. 1998), the human and
mouse orthologues appear to show some additional ex-
pression in motor-neuron progenitors. In mouse, the ex-
pression of Hlxb9 in dividing motor-neuron progenitors
is indicated by the presence of BrdU1/Hb91 cells and
Lim31/Hb91/Isl1- cells (Arber et al. 1999), and ex-
pression of human HLXB9 in the subventricular zone
(see fig. 2d, f) may suggest that, as it is in the mouse,
HLXB9 is also expressed in some cells at an earlier stage
of the cell cycle than in the chick. The only direct spinal
cord feature of Currarino syndrome is spinal cord teth-
ering, but it is unclear whether or how this expression
is related to the observed HLXB9 expression patterns.
In contrast to patients with Currarino syndrome, Hlxb9
2/2 knockout mice have motor-neuron abnormalities
(Arber et al. 1999; Thaler et al. 1999), and in mouse,
Hlxb9 is required to consolidate and, possibly, maintain
motor-neuron identity within the spinal cord. Its ab-
sence, in Hlxb92/2 knockout mice, leads to an in-
creased number of V2 interneurons as well as abnor-
malities of motor-neuron projection. They, however, are
not restricted to the sacral region but occur at all levels
of the spinal cord examined (Arber et al. 1999; Thaler
et al. 1999).
HLXB9 expression in the developing gut shows sig-
nificant differences when compared to mouse Hlxb9 ex-
pression. HLXB9 is expressed in the developing foregut
(the pharynx, esophagus, and, transiently, in the stom-
ach; fig. 3b, c), but, despite detailed examination, no
expression could be detected in either the midgut (fig.
2b) or the hindgut (data not shown). Patients in our
series with HLXB9 mutations do not manifest abnor-
malities in tissues deriving from the foregut, possibly as
a result of functional compensation or lack of sensitivity
in such tissues to 50% dosage, whereas hindgut is ex-
pected to be relevant to the human pathogenesis. In the
embryonic period studied (CS12–CS21), there is major
development of the hindgut, including the caudal exten-
sion of the urorectal septum that divides the cloaca into
the anterior portion, containing the primitive urogenital
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sinus, and the posterior anorectal canal. The urorectal
septum reaches the cloacal membrane, which then rup-
tures to form the anus at CS18/CS19. Incorrect growth
and positioning of the urorectal septum could lead to
the anorectal malformations and abnormal bifurcations
of the urogenital system seen in a proportion of patients
with Currarino syndrome. In mouse, no expression of
Hlxb9 is reported in the hindgut at comparable embry-
onic stages. Hlxb9 expression has been shown in the
entire dorsal gut endoderm at very early stages (E8),
which persists in both the foregut (esophagus and stom-
ach) and also, unlike in humans, the midgut (Harrison
et al. 1999; Li et al. 1999). It is known that there are
considerable differences in the timing of human and ro-
dent gut differentiation at later stages to the ones studied
here: after ∼8–10 wk of development in human and 13
embryonic d in mouse (Klein 1989; Kedinger 1994). Dif-
ferences in gene-expression patterns at earlier stages
could be important in establishing the later differences
in the timing of morphological and differentiation
events. Other studies have also shown differences in gene
expression in gut development between human and
mouse at early stages (e.g., Yamaguchi et al. 1999; Foug-
erousse et al. 2000; see also Lindsay et al. 1997).
Our expression study shows that HLXB9 is expressed
early in human pancreatic development, at the time be-
fore fusion of the dorsal and ventral buds. Expression
is detected earlier in the dorsal bud compared to ventral
bud, possibly because of the very small initial size of the
latter. In mouse, Hlxb9 expression is detectable in both
dorsal and ventral pancreatic buds at E9.5, but its ex-
pression rapidly decreases, initially in the ventral bud,
and is undetectable in both dorsal and ventral buds by
E10.5/E11.5. At later stages, expression is again detected
becoming progressively more restricted to the beta cells
of the islets of Langerhans (Harrison et al. 1999; Li et
al. 1999). This is unlike HLXB9, which in human con-
tinues to be expressed throughout the period studied
with no obvious differences in intensity of expression
between the dorsal and ventral buds after CS15. These
differences in the timing of expression and relative in-
tensities of expression between the dorsal and ventral
buds may reflect underlying differences in the develop-
ment of human and murine pancreas.
Although pancreatic malformations or malfunction
have not been described in Currarino syndrome, pan-
creatic HLXB9 expression is of interest given the as-
sociation between maternal diabetes and caudal dyspla-
sia (Kalter 1993) and the caudal malformations elicited
in animals as a result of the teratogenic effects of insulin
(reviewed by Alles and Sulik 1993). There is a wide
spectrum of defects seen in caudal dysplasia, including
abnormalities of the sacrum and hindgut (Pang 1993),
but the possibility that HLXB9 may be involved is raised
by the reports of several patients with 7q36 deletions
(Morichon-Delvallez 1993; Savage et al. 1997). It is in-
teresting that neuronal abnormalities are part of the
spectrum of caudal dysplasia, with motor nerves being
more severely affected than sensory ones (Pang 1993).
We are currently undertaking a mutation study of caudal
dysplasia patients to assess the involvement of HLXB9
in these disorders.
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